July 10 (Reuters) - Knight Therapeutics Inc:
* KNIGHT ANNOUNCES NORMAL COURSE ISSUER BID
* KNIGHT THERAPEUTICS - PROPOSES TO PURCHASE, FROM TIME TO TIME OVER NEXT 12 MONTHS, IF CONSIDERED ADVISABLE, UP TO 10.9 MILLION COMMON SHARES OF CO Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.